Antiviral Research

Top Research Topics at Antiviral Research?

The journal focuses largely on the fields of Virology, Virus, Immunology, Viral replication and Molecular biology. Issues in Virology were discussed, taking into consideration concepts from other disciplines like Cell culture, In vitro and Microbiology. Virus research presented in it encompasses a variety of subjects, including Antibody and In vivo.

In the Immunology research discussed, Immune system and Viral load are all tackled. The concepts on Molecular biology presented in the journal can also apply to other research fields, including RNA and Biochemistry.

• Virology (64.76%)
• Virus (37.29%)
• Immunology (13.98%)

What are the most cited papers published in the journal?

• Present and future arboviral threats. (962 citations)
• The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. (943 citations)
• The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. (922 citations)

Research areas of the most cited articles at Antiviral Research:

The journal articles focus largely on the fields of Virology, Virus, Immunology, Viral replication and Microbiology. The published articles link adjacent topics like Virology with Cell culture. The journal papers tackle studies in In vitro and the interrelated subject of In vivo to gain insights into Virus.

What topics the last edition of the journal is best known for?

• Virus
• Gene
• Enzyme

The previous edition focused in particular on these issues:

The main research concerns discussed in the journal are Virology, Virus, Viral replication, In vitro and Hepatitis B virus. The work on Virology presented in it focuses on Antiviral drug in particular. The field of Immunology is the anchor for the Virus studies presented in Antiviral Research.

It addresses concerns in the field of Viral replication by exploring it in line with topics in Cell biology which intersect with Transcription (biology) subjects. Antiviral Research tackles studies in In vivo and the interrelated subject of Viral load to gain insights into In vitro. The work on Hepatitis B virus addressed in the journal expands to the thematically related Hepatitis B.

The most cited articles from the last journal are:

• Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir. (9 citations)
• Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. (9 citations)
• A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Antiviral Research (based on the number of publications) are:

• Erik De Clercq (188 papers) absent at the last edition,
• Jan Balzarini (159 papers) absent at the last edition,
• Johan Neyts (146 papers) published 4 papers at the last edition the same number as at the previous edition,
• Robert Snoeck (100 papers) absent at the last edition,
• Graciela Andrei (96 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Antiviral Research (based on the number of publications) are:

• Rega Institute for Medical Research (307 papers) published 3 papers at the last edition, 2 less than at the previous edition,
• National Institutes of Health (199 papers) published 2 papers at the last edition, 11 less than at the previous edition,
• Utah State University (155 papers) published 3 papers at the last edition, 1 less than at the previous edition,
• University of Texas Medical Branch (92 papers) published 2 papers at the last edition, 3 less than at the previous edition,
• Chinese Academy of Sciences (86 papers) published 1 paper at the last edition, 5 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.54% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.31% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.69% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.72% of all publications and 63.28% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.